Heart failure in chronic kidney disease: from epidemiology to therapy

Many patients affected by chronic kidney disease (CKD) die before reaching endstage renal disease because of cardiovascular disease (CVD). Recent guidelines and position statements have therefore defined CKD as a cardiovascular risk equivalent, and patients in all stages of CKD are considered in the...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Giornale italiano di nefrologia 2007-11, Vol.24 (6), p.574-583
Hauptverfasser:	Zamboli, P, De Nicola, L, Minutolo, R, Stanzione, G, Bertino, V, Sosio, R, De Luca, A, Crivaro, M, Tassinario, S, Conte, G
Format:	Artikel
Sprache:	ita
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Angiotensin II Type 1 Receptor Blockers - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Heart Failure - drug therapy Heart Failure - etiology Heart Failure - physiopathology Humans Kidney Failure, Chronic - complications Kidney Failure, Chronic - epidemiology Mineralocorticoid Receptor Antagonists
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!